Shielding for Critical Organs and Radiation Exposure Dose Distribution in Patients with High Energy Radiotherapy

고 에너지 방사선치료에서 환자의 피폭선량 분포와 생식선의 차폐

  • Chu, Sung-Sil (Department of radiation Oncology, College of Medicine Yonsei University) ;
  • Suh, Chang-Ok (Department of radiation Oncology, College of Medicine Yonsei University) ;
  • Kim, Gwi-Eon (Department of radiation Oncology, College of Medicine Yonsei University)
  • 추성실 (연세대학교 의과대학 방사선종양학교실) ;
  • 서창옥 (연세대학교 의과대학 방사선종양학교실) ;
  • 김귀언 (연세대학교 의과대학 방사선종양학교실)
  • Published : 2002.03.30


High energy photon beams from medical linear accelerators produce large scattered radiation by various components of the treatment head, collimator and walls or objects in the treatment room including the patient. These scattered radiation do not provide therapeutic dose and are considered a hazard from the radiation safety perspective. Scattered dose of therapeutic high energy radiation beams are contributed significant unwanted dose to the patient. ICRP take the position that a dose of 500mGy may cause abortion at any stage of pregnancy and that radiation detriment to the fetus includes risk of mental retardation with a possible threshold in the dose response relationship around 100 mGy for the gestational period. The ICRP principle of as low as reasonably achievable (ALARA) was recommended for protection of occupation upon the linear no-threshold dose response hypothesis for cancer induction. We suggest this ALARA principle be applied to the fetus and testicle in therapeutic treatment. Radiation dose outside a photon treatment filed is mostly due to scattered photons. This scattered dose is a function of the distance from the beam edge, treatment geometry, primary photon energy, and depth in the patient. The need for effective shielding of the fetus and testicle is reinforced when young patients ate treated with external beam radiation therapy and then shielding designed to reduce the scattered photon dose to normal organs have to considered. Irradiation was performed in phantom using high energy photon beams produced by a Varian 2100C/D medical linear accelerator (Varian Oncology Systems, Palo Alto, CA) located at the Yonsei Cancer Center. The composite phantom used was comprised of a commercially available anthropomorphic Rando phantom (Phantom Laboratory Inc., Salem, YN) and a rectangular solid polystyrene phantom of dimensions $30cm{\times}30cm{\times}20cm$. the anthropomorphic Rando phantom represents an average man made from tissue equivalent materials that is transected into transverse 36 slices of 2.5cm thickness. Photon dose was measured using a Capintec PR-06C ionization chamber with Capintec 192 electrometer (Capintec Inc., Ramsey, NJ), TLD( VICTOREEN 5000. LiF) and film dosimetry V-Omat, Kodak). In case of fetus, the dosimeter was placed at a depth of loom in this phantom at 100cm source to axis distance and located centrally 15cm from the inferior edge of the $30cm{\times}30cm^2$ x-ray beam irradiating the Rando phantom chest wall. A acryl bridge of size $40cm{\times}40cm^2$ and a clear space of about 20 cm was fabricated and placed on top of the rectangular polystyrene phantom representing the abdomen of the patient. The leaf pot for testicle shielding was made as various shape, sizes, thickness and supporting stand. The scattered photon with and without shielding were measured at the representative position of the fetus and testicle. Measurement of radiation scattered dose outside fields and critical organs, like fetus position and testicle region, from chest or pelvic irradiation by large fie]d of high energy radiation beam was performed using an ionization chamber and film dosimetry. The scattered doses outside field were measured 5 - 10% of maximum doses in fields and exponentially decrease from field margins. The scattered photon dose received the fetus and testicle from thorax field irradiation was measured about 1 mGy/Gy of photon treatment dose. Shielding construction to reduce this scattered dose was investigated using lead sheet and blocks. Lead pot shield for testicle reduced the scatter dose under 10 mGy when photon beam of 60 Gy was irradiated in abdomen region. The scattered photon dose is reduced when the lead shield was used while the no significant reduction of scattered photon dose was observed and 2-3 mm lead sheets refuted the skin dose under 80% and almost electron contamination. The results indicate that it was possible to improve shielding to reduce scattered photon for fetus and testicle when a young patients were treated with a high energy photon beam.


  1. NCRP report 91. 'Recommendations on limits for exposure to ionizing radiation', National Council on Radiation Protection and Measurements, Bethesda, MD 20814, (1987)
  2. ICRP report 60. 1990 Recommendations of the International Commission on Radiological Protection Pergamon, Oxford, (1991)
  3. ICRP report 44. Protection of the Patient in Radiation Therapy Pergamon, Oxford, (1991)
  4. ICRP report 49. Developmental Effects of Irradiation on the Brain of the Embryo and Fetus Pergamon, Oxford, (1986)
  5. ICRP report 26. 'Recommendations of the International Commission on Radiological Protection Pergamon', Oxford, (1977)
  6. E.J. Hall. Radiobiology for the Radiologist, 5th ed. J.B. Lippincott, New York, (2000)
  7. H. Ing, W.R. Nelson and R.A. Shore. 'Unwanted photon and' neutron radiation resulting from collimated photon beams interacting with the body of radiotherapy patients.' Med. Phys. 9,27-33 (1982)
  8. J.A. Antolak and E.A. Strom. 'Fetal dose estimates for electron beam treatment to the chest wall of a pregnant woman.' Med. Phys. 25,2388-2391(1998)
  9. M. Mazonakis, J. Damilakis, N. Theohaveris and N. Gourtsoyiannis, 'Brain radiotherapy during pregnancy : An analysis of conceptus dose using anthropomorphic phantoms.' Br. J. Radiol. 72,274-278(1999)
  10. S.C. Roy and G.A. Sandison. 'Shielding for neutron scattered dose to the fetus in patients teated with 18 MV x-ray beams.' Med. PHys. 27,1800-180 (2000)
  11. R.Neta. 'The promise of molecular epidemilolgy in defining the association between radiation and cancer.' Health Physics, 79,77-84 (2000)
  12. T.D. Luckey, 'Radiation hormesis overview' Radiation Protection Management, 22-34, July/August, (1999)
  13. C.A.Perez, L.W.Brady. 'Principles and practice of radiation oncology.' 2nd edition JB Lippincott company. NY (1992)
  14. 방사선 안전관리 등의 기술기준에 관한 규칙. 과학기술부령 제 17호 (2000.4.18)